会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Extracorporeal xenogeneic organ perfusion following antibody depletion by immunoapheresis
    • 抗体后体外异种器官灌注通过还原Immunoapherese
    • EP0775493A3
    • 1998-08-12
    • EP96118698
    • 1996-11-21
    • BAXTER INT
    • MULLER-DERLICH JUTTA
    • A61K35/14A61M1/36A61M1/34
    • A61K35/16A61M1/3621A61M2202/0417B01D15/3809A61M2202/0057
    • The invention provides a method for treating a patient in need of ex vivo perfusion of his/her blood through a pig organ comprising first passing plasma from the patient over a column coupled to anti-human immunoglobulin antibodies, thereby removing a significant portion of the immunoglobulin from the patient's plasma, recombining the patient's immunoglobulin-depleted plasma with the patient's red blood cells, perfusing the patient's immunoglobulin-depleted blood through the pig organ, and then reinfusing the blood to the patient. Depletion of immunoglobulin removes anti-pig natural antibodies which would otherwise cause a hyperacute rejection reaction in the pig organ, thus quickly destroying the organ within 2-6 hours. The invention allows a single pig organ to function well in ex vivo perfusion for a much longer time, without signs of hyperacute rejection in the organ. The invention is especially useful in cases of acute liver failure where ex vivo perfusion of the patient's blood through a pig liver can bring the patient out of hepatic coma and bridge the patient to liver transplant. In some cases, the patient's liver may begin functioning on its own again after the treatment, thus altogether abrogating the need for liver transplant. The invention is also directed to the use of anti-human immunoglobulin antibodies in the manufacture of a column coupled to said antibodies for the pre-treatment of the plasma of a patient prior to ex vivo perfusion of the patient's blood through a pig organ.